Concepedia

Michael P. Gosland

MP

17

Publications

1.2K

Citations

15

H-Index

1989

Active since

Affiliations

University of Kentucky(Current)

Stanford University

Markey Cancer Center

University of the Pacific

Albert B. Chandler Hospital

Michael P. Gosland is an author at University of Kentucky specializing in medicine, pharmacology, and cell biology.

Top concepts

Publications per year

1989–1997

17

Publications

17

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

B L Lum, Sonja Kaubisch, Alan M. Yahanda et al. · Journal of Clinical Oncology · 1992 · 298 citations

, , +12

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

Alan M. Yahanda, K M Alder, George A. Fisher et al. · Journal of Clinical Oncology · 1992 · 218 citations

MDR Expression in Normal Tissues: Pharmocologic Implication for the Clinical Use of P-Glycoprotein Inhibitors

Bert L. Lum, Michael P. Gosland · Hematology/Oncology Clinics of North America · 1995 · 131 citations

Molecular Targets in Oncology: Implications of the Multidrug Resistance Gene

Bert L. Lum, Michael P. Gosland, Sonja Kaubisch et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1993 · 92 citations

Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells.

Michael P. Gosland, B L Lum, Branimir I. Šikić · PubMed · 1989 · 75 citations

, , +15

Rows per page

1–5 of 17